Emergent BioSolutions Inc. (EBS) has a market capitalization of $448.34M and trades at $8.66. The 52-week range is 4.02-14.06.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 8.8, Earnings Per Share (EPS) of $0.98, annual revenue of $742.9M.
The stock has a beta of 2.36, operates in the Healthcare sector.
